| Contact lenses use |
10/17 (58.8) |
| History of ocular surgery |
7/17 (41.2) |
| Eye disorders affecting the ocular surface |
6/17 (35.3) |
| Meibomitis, seborrheic MGD, and excessive meibomian lipid secretion |
4/17 (27.5) |
| Topical medical therapy (of any kind) |
4/17 (27.5) |
| Infectious conjunctivitis |
4/17 (27.5) |
| Systemic diseases affecting the ocular surface |
4/17 (27.5) |
| Topical or systemic steroids use |
3/17 (17.6) |
| Active ocular disease |
3/17 (17.6) |
| Pregnancy or childbearing age without contraception |
3/17 (17.6) |
| Stevens-Johnson syndrome |
3/17 (17.6) |
| Chemical, thermal, or radiation injury |
3/17 (17.6) |
| Decreased reflex tearing (<10 mm/5 min Schirmer test result) |
2/17 (11.8) |
| Diabetes |
2/17 (11.8) |
| Current treatment for blepharitis |
2/17 (11.8) |
| Topical or systemic antibiotics |
2/17 (11.8) |
| Alteration of lacrimal drainage system |
2/17 (11.8) |
| Drugs affecting tearing |
2/17 (11.8) |
| Sjögren's syndrome |
2/17 (11.8) |
| MGD with acute inflammation |
2/17 (11.8) |
| Anterior blepharitis with more than moderate severity |
2/17 (11.8) |
| Active ocular allergy |
2/17 (11.8) |
| Inflammatory diseases unrelated to MGD |
2/17 (11.8) |
| Ocular adnexal pathology interfering with warm compress application |
2/17 (11.8) |
| Lid structural abnormality |
2/17 (11.8) |
| Topical or systemic antimetabolites |
1/17 (5.9) |
| Eyelid surgery |
1/17 (5.9) |
| Use of isotretinoin within the past 6 months |
1/17 (5.9) |
| Autoimmune disease requiring treatment |
1/17 (5.9) |
| Smokers |
1/17 (5.9) |
| Punctal plugs |
1/17 (5.9) |
| Anterior chamber inflammation |
1/17 (5.9) |
| Glaucoma |
1/17 (5.9) |
| Anterior segment diseases |
1/17 (5.9) |
| Best corrected visual acuity <1.0 logMAR |
1/17 (5.9) |
| Lid skin disease |
1/17 (5.9) |
| Cicatricial conjunctival diseases |
1/17 (5.9) |
| Sensitivity to study medication |
1/17 (5.9) |
